Hemminki K, Kyyrönen P
Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden.
Genet Epidemiol. 2000 Sep;19(2):149-59. doi: 10.1002/1098-2272(200009)19:2<149::AID-GEPI3>3.0.CO;2-H.
We used the nationwide Swedish Family-Cancer Database to assess familial risks to sibs in sibsibs where at least two sibs had concordant cancer and their parents either concordant or discordant cancer. Familial relative risks (FRRs) were calculated by comparing to concordant sib-pairs whose parents had no cancer. Cancer sites were included if at least ten such concordant sib-pairs were found. In situ cancers were included in order to increase the numbers of cases. Concordant triads, one parent and the sib-pair affected, had an FRR over 100 for thyroid (FRR 399), colon, all bowel, and ovarian cancer. In these cancers, some 40% or more of the concordant sib-pairs belonged to this group. Melanoma and cancer of the nervous system showed FRRs of about 20, and invasive breast cancer of only 2. 9; in these cancers no more than 10% of the concordant sib-pairs belonged to the concordant triads. Discordant family sets, one or two parents presenting with a cancer discordant from that of the sib-pair, showed an FRR of about 3.0 and breast cancer about 2.0, suggesting the involvement of familial effects shared by many forms of cancer.
我们使用瑞典全国性家庭癌症数据库,评估至少有两个兄弟姐妹患癌情况一致且其父母患癌情况一致或不一致的兄弟姐妹中,同胞患癌的家族风险。通过与父母无癌症的患癌情况一致的同胞对进行比较,计算家族相对风险(FRR)。如果发现至少十个这样患癌情况一致的同胞对,则纳入相应癌症部位。为了增加病例数量,原位癌也被纳入。父母一方及同胞对均患癌的一致三联体中,甲状腺癌(FRR 399)、结肠癌、所有肠道癌和卵巢癌的FRR超过100。在这些癌症中,约40%或更多患癌情况一致的同胞对属于这一组。黑色素瘤和神经系统癌症的FRR约为20,浸润性乳腺癌的FRR仅为2.9;在这些癌症中,不超过10%患癌情况一致的同胞对属于一致三联体。父母一方或双方患癌情况与同胞对不一致的不一致家庭组,FRR约为3.0,乳腺癌约为2.0,这表明多种癌症存在共同的家族影响因素。